Exicure (XCUR) Asset Utilization Ratio (2017 - 2024)

Exicure's (XCUR) quarterly Asset Utilization Ratio came in at 0.04 in Q4 2024, down 17.0% on a QoQ basis from 0.05 in Q3 2024.

Exicure (XCUR) Asset Utilization Ratio (2017 - 2024) Analysis & Trends

Exicure (XCUR) has 8 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2024.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.04 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.04 (changed N/A YoY) and the FY2024 annual result came in at 0.04, changed N/A from the prior year.
Asset Utilization Ratio slipped to 0.04 in Q4 2024, from 0.05 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 1.43 in Q3 2023 to a low of 0.04 in Q4 2021.
A 5-year average of 0.32 and a median of 0.09 in 2020 frame the typical range for Asset Utilization Ratio.
Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 2888.01% — and 2024, when it plunged 96.71%.
Tracing XCUR's Asset Utilization Ratio over 5 years: stood at 0.16 in 2020, then plunged by 76.48% to 0.04 in 2021, then jumped by 2888.01% to 1.1 in 2022, then climbed by 29.43% to 1.43 in 2023, then sank by 97.27% to 0.04 in 2024.
The last three Asset Utilization Ratio figures came in at 0.04 (Q4 2024), 0.05 (Q3 2024), and 0.05 (Q2 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.38
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.90
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.13
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Exicure	7.27 Mn	7.27 Mn	-	-

Download Data